Tanke Biosciences Stock Probability of Future Pink Sheet Price Finishing Over 53.69
| TNBI Stock | USD 0.02 0.01 33.33% |
Tanke |
Tanke Biosciences Target Price Odds to finish over 53.69
The tendency of Tanke Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 53.69 or more in 90 days |
| 0.02 | 90 days | 53.69 | close to zero percent |
Based on a normal probability distribution, the odds of Tanke Biosciences to move over $ 53.69 or more in 90 days from now is close to zero percent (This Tanke Biosciences probability density function shows the probability of Tanke Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Tanke Biosciences price to stay between its current price of $ 0.02 and $ 53.69 at the end of the 90-day period is about 16.91 .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 3.77 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Tanke Biosciences will likely underperform. In addition to that Tanke Biosciences has an alpha of 6.1975, implying that it can generate a 6.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Tanke Biosciences Price Density |
| Price |
Predictive Modules for Tanke Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tanke Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tanke Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tanke Biosciences is not an exception. The market had few large corrections towards the Tanke Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tanke Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tanke Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 6.20 | |
β | Beta against Dow Jones | 3.77 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.12 |
Tanke Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tanke Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tanke Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tanke Biosciences is way too risky over 90 days horizon | |
| Tanke Biosciences has some characteristics of a very speculative penny stock | |
| Tanke Biosciences appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 28.56 M. Net Loss for the year was (210.25 K) with profit before overhead, payroll, taxes, and interest of 9.94 M. | |
| Tanke Biosciences currently holds about 5.09 M in cash with (1.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Tanke Biosciences Technical Analysis
Tanke Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Tanke Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tanke Biosciences. In general, you should focus on analyzing Tanke Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Tanke Biosciences Predictive Forecast Models
Tanke Biosciences' time-series forecasting models is one of many Tanke Biosciences' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tanke Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Tanke Biosciences
Checking the ongoing alerts about Tanke Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tanke Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Tanke Biosciences is way too risky over 90 days horizon | |
| Tanke Biosciences has some characteristics of a very speculative penny stock | |
| Tanke Biosciences appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 28.56 M. Net Loss for the year was (210.25 K) with profit before overhead, payroll, taxes, and interest of 9.94 M. | |
| Tanke Biosciences currently holds about 5.09 M in cash with (1.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Tanke Pink Sheet
Tanke Biosciences financial ratios help investors to determine whether Tanke Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tanke with respect to the benefits of owning Tanke Biosciences security.